Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond

MD Parkins, BE Lee, N Acosta, M Bautista… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Wastewater-based surveillance (WBS) has undergone dramatic advancement in the context
of the coronavirus disease 2019 (COVID-19) pandemic. The power and potential of this …

Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized …

M Riccò, A Cascio, S Corrado, M Bottazzoli, F Marchesi… - Vaccines, 2024 - mdpi.com
A systematic review and meta-analysis was designed in order to ascertain the effectiveness
of respiratory syncytial virus (RSV) vaccination in preventing lower respiratory tract diseases …

Public health impact of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among older adults in the United States

D Molnar, EM La, F Verelst, S Poston, J Graham… - Infectious Diseases and …, 2024 - Springer
Introduction Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract
disease in older adults, resulting in substantial morbidity and mortality. Methods This study …

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

MG Ison, A Papi, E Athan, RG Feldman… - Clinical Infectious …, 2024 - academic.oup.com
Background The adjuvanted RSV prefusion F protein–based vaccine (RSVPreF3 OA) was
efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) in≥ 60-years …

Respiratory Syncytial Virus Infection in Older Adults: An Update

F Alfano, T Bigoni, FP Caggiano, A Papi - Drugs & Aging, 2024 - Springer
Respiratory syncytial virus (RSV) infection represents one of the most common infections
during childhood, with significant morbidity and mortality in newborns and in the early years …

The in vitro and in vivo antiviral effects of IGF1R inhibitors against respiratory syncytial virus infection

P Ruan, P Dai, Y Mao, Z Tang, H He, G Wu… - Journal of …, 2024 - Taylor & Francis
The insulin-like growth factor 1 receptor (IGF1R) was recognized as a pivotal receptor that
facilitated the cellular entry of RSV. Small molecule inhibitors designed to target IGF1R …

The changing landscape of infections in the lung transplant recipient

J Lum, C Koval - Current Opinion in Pulmonary Medicine, 2024 - journals.lww.com
The changing landscape of infections in the lung transplant recipient Page 1 MCP 300404
CURRENT OPINION The changing landscape of infections in the lung transplant recipient …

Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy

D Ponticelli, L Losa, IC Antonazzo, A Zampella… - Infectious Disease …, 2024 - mdpi.com
As respiratory syncytial virus (RSV) vaccine distribution gains traction in Europe and Italy,
healthcare workers (HCWs) can strategize about vaccine promotion to increase uptake …

New vaccines for chronic respiratory patients

N Mallah, AD Urbieta, IR Calle… - Archivos de …, 2024 - Elsevier
Chronic respiratory diseases (CRDs) are responsible for more than four million deaths
worldwide and have become especially prevalent in developed countries. Although the …

So we now have RSV vaccines. What's our next steps?

JM Blondeau - Expert Review of Respiratory Medicine, 2024 - Taylor & Francis
Respiratory viral infections have a major impact on human health and the newly approved
vaccines for respiratory syncytial virus (RSV) are a welcomed addition for prevention of …